Paulson Richard A.

President And CEO

1 company

Excellent

Trades Analyzed

12M Win Rate

94.9%

Avg 3M Return

+16.9%

Avg 12M Return

+49.9%

Paulson Richard A. is a President And CEO at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $1.8M based on current market prices.

Holdings by Company

KPTIOct 15, 2025

Current Shares198.3K

Value$1.76M

Net Activity-292,024

Bought: 0Sold: 292.0K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 15, 2025	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	1,257	$6.43	$8,082.51	-1.5%	+7.2%	-
May 6, 2025	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	236	$7.12	$1,680.32	-0.3%	-35.9%	+39.9%
Apr 4, 2025	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	245	$3.74	$916.30	-0.3%	+13.7%	+63.7%
Mar 4, 2025	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	11,694	$6.29	$73,555.26	-12.4%	-35.3%	+43.1%
Feb 4, 2025	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	4,099	$0.65	$2,664.35	-0.4%	-23.7%	-32.2%
Jan 6, 2025	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	4,055	$0.78	$3,175.07	-0.4%	-67.5%	-40.9%
Dec 4, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,620	$0.81	$2,932.20	-0.3%	-46.6%	-50.4%
Nov 5, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,675	$0.91	$3,346.46	-0.3%	-26.4%	-57.7%
Oct 4, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,607	$0.88	$3,171.64	-0.3%	-8.5%	-52.1%
Sep 4, 2024	KPTI Karyopharm Therapeutics Inc.	President And CEO	Sell	3,667	$0.72	$2,646.84	-0.3%	+13.7%	-37.0%